Nano Biomedicine and Engineering · 2022 · 33 citations · 21 references
PharmacyBioengineeringPharmaceuticsMagnetic MaterialsNanobiotechnologyNanomaterialsCancer NanomedicineInorganic NanoparticlesMagnetic NanomaterialsNanomedicineNanoparticle CharacterizationNanoparticle DesignIron Oxide NanoparticlesMagnetic NanoparticlesMagnetic Oxide NanoparticlesMagnetic PropertiesNanoparticle Cellular UptakeNanoparticle-based Contrast AgentsNanoparticlesSuperparamagnetic Contrast Agents
Effective and specific diagnostic imaging of brain glioma remains a challenge. Magnetic nanoparticles are actively being developed as contrast agents for diagnosis of tumor. In this work, we developed the targeted magnetic nanoparticles as T<sub>1</sub>-positive magnetic resonance imaging (MRI) contrast agents. Zn-doped Fe<sub>3</sub>O<sub>4</sub> NPs were synthesized by solvothermal method, coated with liposome and conjugated to a tumor-penetrating peptide (RGERPPR). The effect of zinc doping on the magnetic properties of Fe<sub>3</sub>O<sub>4</sub> nanoparticles was studied. Zn<sub>0.4</sub>Fe<sub>2.6</sub>O<sub>4</sub>-PEG nanoparticles exhibited T<sub>1</sub> MR contrast enhancement. Cytotoxicity assay indicated that nanoparticles have good biocompatibility and low toxicity. And the in vitro cellular uptake assays on U87 cells confirmed that the conjugation of RGERPPR increased the uptake of the Zn<sub>0.4</sub>Fe<sub>2.6</sub>O<sub>4</sub> NPs. In vivo MR imaging showed the contrast enhance of U87 brain glioma in rat model after injection.
21